Methotrexate: A Drug of the Future in Ulcerative Colitis?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|10|1413-1416

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.10, 2011-09, pp. : 1413-1416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ulcerative Colitis: Pathogenesis

By  

Current Drug Targets, Vol. 12, Iss. 10, 2011-09 ,pp. : 1373-1382

Bentham Science Publishers

Access to resources Recommend Favorite

Drug treatment of ulcerative colitis: unfractionated heparin, low molecular weight heparins and beyond

By Malhotra Samir   Bhasin Deepak   Shafiq Nusrat   Pandhi Promila  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 329-334

Informa Healthcare

Access to resources Recommend Favorite

Development and characterization of colon specific drug delivery system bearing 5-ASA and camylofine dihydrochloride for the treatment of ulcerative colitis

By Dubey Rupal   Dubey Rounak   Omrey Pratibha   Vyas S.P.   Jain S.K.  

Journal of Drug Targeting, Vol. 18, Iss. 8, 2010-09 ,pp. : 589-601

Informa Healthcare

Access to resources Recommend Favorite

Investigating Drug Repositioning Approach to Design Novel Prodrugs for Colon-specific Release of Fexofenadine for Ulcerative Colitis

By  

Current Drug Delivery, Vol. 14, Iss. 4, 2017-07 ,pp. : 543-554

Bentham Science Publishers

Access to resources Recommend Favorite

Endoscopic diagnosis of refractory ulcerative colitis

By Hirata I.   Murano M.  

Inflammopharmacology, Vol. 15, Iss. 1, 2007-02 ,pp. : 22-25

Springer Publishing Company

Access to resources Recommend Favorite